Pharm-Olam

pharm-olam.com · Houston, United States of America

Pharm-Olam is a contract research organization that provides clinical trial management and related services to pharmaceutical, biotechnology, and medical device companies. The company supports Phase I–IV clinical studies across multiple therapeutic areas, offering services such as project management, monitoring, data management, and regulatory support. It generates revenue through fee-for-service and outsourced clinical development contracts with life sciences sponsors.

Revenue
$50M - $250M
Employees
201 - 1,000
Founded
1994
Headquarters
Houston, United States of America

Pharm-Olam customers on Arbolus

Total customers 5 3 current · 2 former
Reviews growth 1 new review since Feb 2026

Customers who reviewed Pharm-Olam

Seniority of Pharm-Olam customers

Most people who reviewed Pharm-Olam hold Director roles (80%), followed by C-Suite (20%).

  • Director 80%
  • C-Suite 20%

Customers sample

Revenue Leader Director NPS 7 Not renewing
Other Leader C-Suite NPS 6 Undecided
Not specified Director NPS 5 Undecided

Employer names and spend open once the report publishes.

What 5 Arbolus experts think of Pharm-Olam

Overall sentiment: Neutral

NPS scores from expert insights range from 5 to 7, reflecting moderate satisfaction levels. Renewal intent is predominantly 'Not Sure' (80% of experts), with only one clear 'No' and zero confirmed renewals. Implementation stickiness shows a split: 60% have been using the solution for more than one year, 20% less than a year, and 20% are at the pilot stage. Key inferred themes are moderate satisfaction, high uncertainty about renewal, and a user base engaged in mature implementations but not committed to ongoing contracts.

Tell us when the Pharm-Olam report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

-40 Net Promoter Score, from 5 scored reviews
  • Promoters 1
  • Passives 1
  • Detractors 3

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 0%
  • Will renew 0
  • Undecided 3
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 1 answer
  • Director 0% 3 answers
  • 5.7/10 Average score from undecided customers
  • 7/10 Average score from customers not renewing

For people who use Pharm-Olam

Do you use Pharm-Olam at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 5 customers of Pharm-Olam have already contributed

Takes a few minutes. Your identity stays anonymous.